Get Premium to unlock powerful stock data

Commodore Capital Lp Buys BELLUS Health Inc, Merus NV, Xenon Pharmaceuticals Inc, Sells , Kura Oncology Inc, Celldex Therapeutics Inc

Author's Avatar
Feb 19, 2022
Article's Main Image
Investment company Commodore Capital Lp (Current Portfolio) buys BELLUS Health Inc, Merus NV, Xenon Pharmaceuticals Inc, Tricida Inc, Protagonist Therapeutics Inc, sells , Kura Oncology Inc, Celldex Therapeutics Inc, Iovance Biotherapeutics Inc, Revolution Medicines Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Commodore Capital Lp. As of 2021Q4, Commodore Capital Lp owns 25 stocks with a total value of $432 million. These are the details of the buys and sells.

For the details of COMMODORE CAPITAL LP's stock buys and sells, go to https://www.gurufocus.com/guru/commodore+capital+lp/current-portfolio/portfolio

These are the top 5 holdings of COMMODORE CAPITAL LP
  1. IVERIC bio Inc (ISEE) - 3,217,163 shares, 12.46% of the total portfolio. Shares added by 16.98%
  2. Merus NV (MRUS) - 1,498,890 shares, 11.04% of the total portfolio. Shares added by 108.72%
  3. Aclaris Therapeutics Inc (ACRS) - 2,672,346 shares, 9.00% of the total portfolio. Shares added by 22.01%
  4. Xenon Pharmaceuticals Inc (XENE) - 1,090,126 shares, 7.89% of the total portfolio. Shares added by 88.14%
  5. Cytokinetics Inc (CYTK) - 704,537 shares, 7.44% of the total portfolio. Shares reduced by 11.55%
New Purchase: BELLUS Health Inc (BLU)

Commodore Capital Lp initiated holding in BELLUS Health Inc. The purchase prices were between $5.26 and $8.3, with an estimated average price of $6.65. The stock is now traded at around $7.000000. The impact to a portfolio due to this purchase was 5.83%. The holding were 3,124,613 shares as of 2021-12-31.

New Purchase: Tricida Inc (TCDA)

Commodore Capital Lp initiated holding in Tricida Inc. The purchase prices were between $4.19 and $9.56, with an estimated average price of $6.54. The stock is now traded at around $9.920000. The impact to a portfolio due to this purchase was 2.76%. The holding were 1,247,043 shares as of 2021-12-31.

New Purchase: Allakos Inc (ALLK)

Commodore Capital Lp initiated holding in Allakos Inc. The purchase prices were between $8.55 and $111.89, with an estimated average price of $80.43. The stock is now traded at around $5.760000. The impact to a portfolio due to this purchase was 1.85%. The holding were 815,667 shares as of 2021-12-31.

Added: Merus NV (MRUS)

Commodore Capital Lp added to a holding in Merus NV by 108.72%. The purchase prices were between $20 and $32.29, with an estimated average price of $28.39. The stock is now traded at around $25.440000. The impact to a portfolio due to this purchase was 5.75%. The holding were 1,498,890 shares as of 2021-12-31.

Added: Xenon Pharmaceuticals Inc (XENE)

Commodore Capital Lp added to a holding in Xenon Pharmaceuticals Inc by 88.14%. The purchase prices were between $24.73 and $35.4, with an estimated average price of $30.08. The stock is now traded at around $31.320000. The impact to a portfolio due to this purchase was 3.7%. The holding were 1,090,126 shares as of 2021-12-31.

Added: Protagonist Therapeutics Inc (PTGX)

Commodore Capital Lp added to a holding in Protagonist Therapeutics Inc by 61.74%. The purchase prices were between $17.63 and $37.1, with an estimated average price of $31.91. The stock is now traded at around $24.850000. The impact to a portfolio due to this purchase was 2.44%. The holding were 805,573 shares as of 2021-12-31.

Added: Aclaris Therapeutics Inc (ACRS)

Commodore Capital Lp added to a holding in Aclaris Therapeutics Inc by 22.01%. The purchase prices were between $12.27 and $18.49, with an estimated average price of $15.09. The stock is now traded at around $13.260000. The impact to a portfolio due to this purchase was 1.62%. The holding were 2,672,346 shares as of 2021-12-31.

Added: VistaGen Therapeutics Inc (VTGN)

Commodore Capital Lp added to a holding in VistaGen Therapeutics Inc by 65.22%. The purchase prices were between $1.67 and $2.76, with an estimated average price of $2.16. The stock is now traded at around $1.390000. The impact to a portfolio due to this purchase was 1.51%. The holding were 8,464,999 shares as of 2021-12-31.

Added: CymaBay Therapeutics Inc (CBAY)

Commodore Capital Lp added to a holding in CymaBay Therapeutics Inc by 29.98%. The purchase prices were between $3.23 and $4.6, with an estimated average price of $3.79. The stock is now traded at around $3.380000. The impact to a portfolio due to this purchase was 0.98%. The holding were 5,419,896 shares as of 2021-12-31.

Sold Out: (DRNA)

Commodore Capital Lp sold out a holding in . The sale prices were between $19.26 and $38.25, with an estimated average price of $29.18.

Sold Out: Kura Oncology Inc (KURA)

Commodore Capital Lp sold out a holding in Kura Oncology Inc. The sale prices were between $12.22 and $19.57, with an estimated average price of $16.12.

Sold Out: Celldex Therapeutics Inc (CLDX)

Commodore Capital Lp sold out a holding in Celldex Therapeutics Inc. The sale prices were between $35.68 and $56.27, with an estimated average price of $43.33.

Sold Out: Iovance Biotherapeutics Inc (IOVA)

Commodore Capital Lp sold out a holding in Iovance Biotherapeutics Inc. The sale prices were between $16.55 and $27.63, with an estimated average price of $21.87.

Sold Out: Revolution Medicines Inc (RVMD)

Commodore Capital Lp sold out a holding in Revolution Medicines Inc. The sale prices were between $24.35 and $33.7, with an estimated average price of $28.17.

Sold Out: Astria Therapeutics Inc (ATXS)

Commodore Capital Lp sold out a holding in Astria Therapeutics Inc. The sale prices were between $5.08 and $8.49, with an estimated average price of $6.54.



Here is the complete portfolio of COMMODORE CAPITAL LP. Also check out:

1. COMMODORE CAPITAL LP's Undervalued Stocks
2. COMMODORE CAPITAL LP's Top Growth Companies, and
3. COMMODORE CAPITAL LP's High Yield stocks
4. Stocks that COMMODORE CAPITAL LP keeps buying
Rating:
0 / 5 (0 votes)
Author's Avatar
WRITTEN BY

GuruFocus Screeners

Related Articles

Q&A with Gurus